A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects

NCT04317885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's B-cell Lymphoma

Interventions

BIOLOGICAL: Prizloncabtagene Autoleucel

Sponsor

Shanghai Tongji Hospital, Tongji University School of Medicine

Collaborators

[object Object]